| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-151 |
Sentence |
denotes |
Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. |
| T1 |
0-151 |
Sentence |
denotes |
Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. |
| T2 |
152-330 |
Sentence |
denotes |
Acute treatment with metformin has a protective effect in myocardial infarction by suppression of inflammatory responses due to activation of AMP-activated protein kinase (AMPK). |
| T2 |
152-330 |
Sentence |
denotes |
Acute treatment with metformin has a protective effect in myocardial infarction by suppression of inflammatory responses due to activation of AMP-activated protein kinase (AMPK). |
| T3 |
331-545 |
Sentence |
denotes |
In the present study, the effect of chronic pre-treatment with metformin on cardiac dysfunction and toll-like receptor 4 (TLR4) activities following myocardial infarction and their relation with AMPK were assessed. |
| T3 |
331-545 |
Sentence |
denotes |
In the present study, the effect of chronic pre-treatment with metformin on cardiac dysfunction and toll-like receptor 4 (TLR4) activities following myocardial infarction and their relation with AMPK were assessed. |
| T4 |
546-759 |
Sentence |
denotes |
Male Wistar rats were randomly assigned to one of 5 groups (n=6): normal control and groups were injected isoproterenol after chronic pre-treatment with 0, 25, 50, or 100mg/kg of metformin twice daily for 14 days. |
| T4 |
546-759 |
Sentence |
denotes |
Male Wistar rats were randomly assigned to one of 5 groups (n=6): normal control and groups were injected isoproterenol after chronic pre-treatment with 0, 25, 50, or 100mg/kg of metformin twice daily for 14 days. |
| T5 |
760-877 |
Sentence |
denotes |
Isoproterenol (100mg/kg) was injected subcutaneously on the 13th and 14th days to induce acute myocardial infarction. |
| T5 |
760-877 |
Sentence |
denotes |
Isoproterenol (100mg/kg) was injected subcutaneously on the 13th and 14th days to induce acute myocardial infarction. |
| T6 |
878-1009 |
Sentence |
denotes |
Isoproterenol alone decreased left ventricular systolic pressure and myocardial contractility indexed as LVdp/dtmax and LVdp/dtmin. |
| T6 |
878-1009 |
Sentence |
denotes |
Isoproterenol alone decreased left ventricular systolic pressure and myocardial contractility indexed as LVdp/dtmax and LVdp/dtmin. |
| T7 |
1010-1122 |
Sentence |
denotes |
The left ventricular dysfunction was significantly lower in the groups treated with 25 and 50mg/kg of metformin. |
| T7 |
1010-1122 |
Sentence |
denotes |
The left ventricular dysfunction was significantly lower in the groups treated with 25 and 50mg/kg of metformin. |
| T8 |
1123-1337 |
Sentence |
denotes |
Metfromin markedly lowered isoproterenol-induced elevation in the levels of TLR4 mRNA, myeloid differentiation protein 88 (MyD88), tumor necrosis factor-alpha (TNF-α), and interleukin 6 (IL-6) in the heart tissues. |
| T8 |
1123-1337 |
Sentence |
denotes |
Metfromin markedly lowered isoproterenol-induced elevation in the levels of TLR4 mRNA, myeloid differentiation protein 88 (MyD88), tumor necrosis factor-alpha (TNF-α), and interleukin 6 (IL-6) in the heart tissues. |
| T9 |
1338-1407 |
Sentence |
denotes |
Similar changes were also seen in the serum levels of TNF-α and IL-6. |
| T9 |
1338-1407 |
Sentence |
denotes |
Similar changes were also seen in the serum levels of TNF-α and IL-6. |
| T10 |
1408-1485 |
Sentence |
denotes |
However, the lower doses of 25 and 50mg/kg were more effective than 100mg/kg. |
| T10 |
1408-1485 |
Sentence |
denotes |
However, the lower doses of 25 and 50mg/kg were more effective than 100mg/kg. |
| T11 |
1486-1627 |
Sentence |
denotes |
Phosphorylated AMPKα (p-AMPK) in the myocardium was significantly elevated by 25mg/kg of metformin, slightly by 50mg/kg, but not by 100mg/kg. |
| T11 |
1486-1627 |
Sentence |
denotes |
Phosphorylated AMPKα (p-AMPK) in the myocardium was significantly elevated by 25mg/kg of metformin, slightly by 50mg/kg, but not by 100mg/kg. |
| T12 |
1628-1806 |
Sentence |
denotes |
Chronic pre-treatment with metformin reduces post-myocardial infarction cardiac dysfunction and suppresses inflammatory responses, possibly through inhibition of TLR4 activities. |
| T12 |
1628-1806 |
Sentence |
denotes |
Chronic pre-treatment with metformin reduces post-myocardial infarction cardiac dysfunction and suppresses inflammatory responses, possibly through inhibition of TLR4 activities. |
| T13 |
1807-1884 |
Sentence |
denotes |
This mechanism can be considered as a target to protect infarcted myocardium. |
| T13 |
1807-1884 |
Sentence |
denotes |
This mechanism can be considered as a target to protect infarcted myocardium. |